|
TW460460B
(en)
|
1997-11-04 |
2001-10-21 |
Chugai Pharmaceutical Co Ltd |
Heterocyclic compounds having NOS inhibitory activities
|
|
JP4064059B2
(ja)
|
1998-04-09 |
2008-03-19 |
明治製菓株式会社 |
インテグリンαＶβ３拮抗剤としてのアミノピペリジン誘導体
|
|
EP1094055B1
(en)
*
|
1998-05-25 |
2006-04-26 |
Santen Pharmaceutical Co., Ltd. |
Novel vinylbenzene derivatives
|
|
GB9818641D0
(en)
*
|
1998-08-26 |
1998-10-21 |
Rh Ne Poulenc Rorer Limited |
Chemical compounds
|
|
US6420396B1
(en)
|
1998-12-16 |
2002-07-16 |
Beiersdorf Ag |
Biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
US6677360B2
(en)
|
1998-12-16 |
2004-01-13 |
Bayer Aktiengesellschaft |
Biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
IL143901A0
(en)
|
1998-12-23 |
2002-04-21 |
Searle & Co |
Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6291503B1
(en)
|
1999-01-15 |
2001-09-18 |
Bayer Aktiengesellschaft |
β-phenylalanine derivatives as integrin antagonists
|
|
AU6315300A
(en)
*
|
1999-07-26 |
2001-02-13 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
US6750219B1
(en)
|
1999-08-05 |
2004-06-15 |
Meiji Seika Kaisha, Ltd. |
Ω-amino-α-hydroxycarboxylic acid derivatives having integrin ανβ3 antagonistic activity
|
|
US20050059669A1
(en)
*
|
1999-10-08 |
2005-03-17 |
Keiichi Ajito |
M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity
|
|
CA2398186A1
(en)
*
|
2000-01-25 |
2001-08-02 |
Mitsuhiro Abe |
Therapeutic agent for reperfusion injury comprising integrin .alpha.v.beta.3 antagonists
|
|
RU2240826C2
(ru)
|
2000-02-03 |
2004-11-27 |
Эйсай Ко., Лтд. |
Ингибитор экспрессии интегрина
|
|
EP1289960A2
(en)
*
|
2000-06-15 |
2003-03-12 |
Pharmacia Corporation |
Cycloalkyl alkanoic acids as integrin receptor antagonists
|
|
US7119098B2
(en)
*
|
2000-06-15 |
2006-10-10 |
Pharmacia Corporation |
Heteroarylakanoic acids as intergrin receptor antagonists
|
|
US20040043988A1
(en)
*
|
2001-06-15 |
2004-03-04 |
Khanna Ish Kurmar |
Cycloalkyl alkanoic acids as intergrin receptor antagonists
|
|
CA2464472C
(en)
|
2001-10-22 |
2014-01-07 |
The Scripps Research Institute |
Antibody targeting compounds
|
|
JP2005533001A
(ja)
*
|
2002-03-04 |
2005-11-04 |
メディミューン，インコーポレーテッド |
インテグリンαｖβ３アンタゴニストを他の物質と併用投与する癌の予防または治療方法
|
|
JP2005525368A
(ja)
*
|
2002-03-04 |
2005-08-25 |
メディミューン，インコーポレーテッド |
インテグリンαｖβ３アンタゴニストをＨＭＧ−ＣｏＡ還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
|
|
WO2004058761A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Pharmacia Corporation |
Pyrazole compounds as integrin receptor antagonists derivatives
|
|
US20050043344A1
(en)
*
|
2002-12-20 |
2005-02-24 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists derivatives
|
|
JP2006516144A
(ja)
*
|
2002-12-20 |
2006-06-22 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニスト誘導体としてのチアゾール化合物
|
|
WO2004066956A2
(en)
*
|
2003-01-30 |
2004-08-12 |
Medimmune, Inc. |
Uses of integrin alphavbeta3 antagonists
|
|
UA87854C2
(en)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
|
TWI396543B
(zh)
*
|
2005-05-12 |
2013-05-21 |
Sankyo Co |
取代丙烯醯胺衍生物及含有它之醫藥組成物
|
|
EP1945262A2
(en)
*
|
2005-10-20 |
2008-07-23 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
WO2008053861A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Santen Pharmaceutical Co., Ltd. |
Novel compound having 1,4-benzoxazin-3-one skeleton
|
|
WO2008053863A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Santen Pharmaceutical Co., Ltd. |
Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
|
|
ES2413504T3
(es)
|
2007-12-21 |
2013-07-16 |
Ligand Pharmaceuticals Inc. |
Moduladores selectivos del receptor de andrógeno (SARM) y usos de los mismos
|
|
WO2010093706A2
(en)
|
2009-02-10 |
2010-08-19 |
The Scripps Research Institute |
Chemically programmed vaccination
|
|
IN2015DN00099A
(enExample)
|
2012-07-18 |
2015-05-29 |
Univ Saint Louis |
|
|
US8716226B2
(en)
|
2012-07-18 |
2014-05-06 |
Saint Louis University |
3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
|
|
WO2015181676A1
(en)
|
2014-05-30 |
2015-12-03 |
Pfizer Inc. |
Carbonitrile derivatives as selective androgen receptor modulators
|
|
CN105272888B
(zh)
*
|
2014-06-24 |
2018-03-27 |
中国科学院上海药物研究所 |
双芳基烯烷酸类化合物及其制备方法和用途
|
|
CN108779077A
(zh)
|
2015-12-30 |
2018-11-09 |
圣路易斯大学 |
作为pan整合素拮抗剂的间位氮杂环氨基苯甲酸衍生物
|
|
BR112021020864A2
(pt)
|
2019-04-19 |
2021-12-14 |
Ligand Pharm Inc |
Formas cristalinas e métodos de produção de formas cristalinas de um composto
|
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|